Clinical trials

  • Vutrisiran for Hereditary (hATTR) transthyretin amyloidosis with cardiomyopathy|Wild-type (wtATTR) transthyretin amyloidosis with cardiomyopathy
  • RUXOLITINIB for Acute lymphoblastic leukemia
  • RUXOLITINIB for Atopic dermatitis
  • Fecal microbiota transplantation for Irritable bowel syndrome | Clostridioides difficile infection
  • Clinical trial in HIV-1 infection
  • L-ASCORBIC ACID for Complex regional pain syndrome (CRPS) type 1 | Algoneurodystrophy
  • Capecitabine for Colon cancer (stage II-III)
  • Oxycodone hydrochloride for Patients undergoing planned surgery classified ASA physical status 1–2
  • Pembrolizumab for Microsatellite instability-high (MSI-H)/mismatch repair deficient (dMMR) tumours | Epstein–Barr virus (EBV)-positive gastric cancer
  • Kayvirus DSM 33474; Kayvirus DSM 33473; Pbunavirus DSM 33593; concentration solution of these bacteriophages for Surgical wound infection|Surgical wound dehiscence
  • TESTOSTERONE CIPIONATE for Paraphilic disorder | Compulsive sexual behaviour disorder
  • selinexor for Relapsed or refractory multiple myeloma